Accumetrics, Inc., developer and marketer of the VerifyNow® System, has received a certificate of registration to ISO 13485:2003, the Quality Management System, a standard developed by the International Organization for Standardization for medical device manufacturers. VerifyNow is the first rapid and easy-to-use diagnostic system for measuring an individual’s response to multiple antiplatelet agents.

“We are extremely pleased to achieve certification to the ISO 13485:2003 standard, which demonstrates our commitment to quality,” says Timothy I. Still, president and CEO of Accumetrics. “With the achievement of this important milestone, we can aggressively pursue our ambitious growth strategies and international expansion plans for 2010.”

Accumetrics is committed to advancing medical understanding of platelet function and enhancing the quality of care for patients receiving antiplatelet therapies by providing industry-leading and widely accessible diagnostic tests for rapid platelet function assessment.

Accumetrics’ VerifyNow System addresses every major antiplatelet drug, including FDA-cleared products for aspirin, P2Y12 inhibitors such as prasugrel and clopidogrel, and GP IIb/IIIa inhibitors such as ReoPro® and Integrilin®. It provides a valuable tool to help physicians make more informed treatment decisions.